Prion pathogenesis is unaltered following down-regulation of SIGN-R1

Barry M Bradford1, Karen L Brown1, Neil A Mabbott1

  • 1The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, Midlothian EH25 9RG, UK.

Virology
|August 15, 2016
PubMed

Insights

SIGN-R1, a molecule on spleen macrophages, does not impact prion disease progression. This finding suggests SIGN-R1 is not essential for prion transport to the brain after peripheral exposure.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Prion diseases are fatal neurodegenerative disorders caused by abnormal prion protein accumulation.
  • Prions replicate in lymphoid tissues on follicular dendritic cells (FDC) before brain infection.
  • Splenic marginal zone macrophages expressing SIGN-R1 are crucial for prion delivery to FDC.

Purpose of the Study:

  • To investigate the role of SIGN-R1 in prion disease pathogenesis.
  • To determine if SIGN-R1 is essential for prion transport and FDC accumulation.

Main Methods:

  • Transiently down-regulated SIGN-R1 expression in mice prior to prion exposure.
  • Assessed early prion accumulation on splenic FDC.
  • Monitored prion spread to the brain.

Main Results:

  • Down-regulating SIGN-R1 did not affect early prion accumulation on splenic FDC.
  • SIGN-R1 down-regulation did not alter prion spread to the brain.
  • The presence of SIGN-R1 on marginal zone macrophages is not rate-limiting for prion disease.

Conclusions:

  • SIGN-R1 expression by marginal zone macrophages is not critical for peripheral prion disease pathogenesis.
  • This study clarifies the role of SIGN-R1 in the initial stages of prion infection.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K